Company News - Crystal Pharmatech Co., Ltd.

27 Mar 2023

Crystal Pharmatech's CDMO Business Unit - Crystal Formulation Services Received China Drug Product Manufacturing License, Achieving the Important Milestone in Formulation Capability

Crystal Formulation Services, a subsidiary of Crystal Pharmatech, has achieved an exciting new milestone in its formulation capabilities. The company was recently granted the "Drug Manufacturing ...

09 Mar 2023

Candoo's Formulation Technology Platform Featured in the Drug Development & Delivery Journal

Crystal Pharmatech, the leading solid state research CRO, is proud to announce that the formulation platform of its subsidiary Candoo Pharmatech Company Inc. to address solubility and bioavailability ...

22 Feb 2023

Industry Shift: FDA Goes Vegan?

Approaching Drug Development With FinesseIn 2012, drug development specialists started an initiative to create predictive Oral Bioavailability Tools (OrBiTo). This initiative recognized the need to mo...

25 Oct 2022

Crystal Pharmatech Returned to AAPS 2022 PharmSci 360

Crystal Pharmatech returned to the American Association of Pharmaceutical Scientists (AAPS) 2022 PharmSci 360 conference alongside pharmaceutical industry players, buyers, and suppliers.

29 May 2022

Crystal Formulation Services（CFS）Opens New Formulation Development Center and Analytical R&D Lab in Suzhou, China

We have both formulation laboratory and pilot GMP-like workshop equipped with a number of international top equipments for oral solid dosage development. The formulation laboratory is mainly used for ...

22 Apr 2022

Crystal Formulation Services, Formulation Tailor-made for Your Molecules

Crystal Pharmatech, the leading solid state research CRO, is proud to announce the opening of a novel, small molecule, formulation CDMO subsidiary known as Crystal Formulation Services (CFS).Crystal P...

14 Jan 2022

Candoo Enables the Successful Development of a BCS 4 Combo Drug Product

This milestone further demonstrates Candoo's expertise in formulation and biopharmaceutics to achieve bioequivalence among different polymorphs and/or salts. For new chemical entities (NCE), it is...

04 Jun 2020

Crystal Pharmatech Expands Leadership Team

Crystal Pharmatech, INC is honored to announce it has hired Dr. Rositza Petrova to Head up US Research and Development efforts. Rosie will report directly to the Head of US Operations and work closely...

04 Aug 2017

International Company Crystal Pharmatech Finds CCIT An Optimal Spot for First US Location

TRENTON (August 4, 2016) – In addition to the dozens of New Jersey entrepreneurs who have used the New Jersey Economic Development Authority's (EDA) Commercialization Center for Innovative Techno...

22 Sep 2015

Crystal Pharmatech Raises $10 Million to Accelerate Growth

On September 15, 2015, Crystal Pharmatech Co., Ltd. Announced the completion of raising $10 million in Series A funding led by Renner Lian he Holdings. Crystal Pharmatech will use the funds to further...

17 Aug 2013

Crystal Pharmatech Triples Headquarters in Biobay, China, with More Floors and Labs

(Suzhou, China) July 16, 2013-Crystal Pharmatech, a leading contract research organization (CRO) which focuses on solid state information for active pharmaceutical ingredients and formulations, has mo...

04 Mar 2013

Crystal Pharmatech and Particle Sciences Form a US-China Pharmaceutical CRO Partnership

By Damain GardeFrom Fierce BiotechPRINCETON, N.J. & SUZHOU, China--Crystal Pharmatech, a technology-driven solid-state research contract research organization (CRO) based in Suzhou, China, announc...

22 Jan 2013

Xceleron and Crystal Pharmatech Announce Partnership to Improve Early Clinical Development Utilizing Absolute Bioavailability Trials and Solid-State Solutions

Xceleron, a U.S.-based leader in the application of ultra-sensitive analytical technology to novel clinical designs, has announced a partnership that will offer drug developers early bioavailability d...

12 Dec 2012

Crystal Pharmatech Introduces Customized Service Packages for Customers Seeking Materials Science Approaches in Drug Discovery and Development

SUZHOU, China--(BUSINESS WIRE)--Crystal Pharmatech, one of the first solid state, technology-driven research laboratories to open in China adopting a Western approach to business and R&D, announce...